S&P 500   4,002.87 (+1.30%)
DOW   32,560.60 (+0.98%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
S&P 500   4,002.87 (+1.30%)
DOW   32,560.60 (+0.98%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
S&P 500   4,002.87 (+1.30%)
DOW   32,560.60 (+0.98%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
S&P 500   4,002.87 (+1.30%)
DOW   32,560.60 (+0.98%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
ETR:AFX

Carl Zeiss Meditec - AFX Stock Forecast, Price & News

€134.35
-3.80 (-2.75%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
€134.35
€139.00
50-Day Range
€126.00
€142.10
52-Week Range
€101.75
€152.35
Volume
76,739 shs
Average Volume
94,405 shs
Market Capitalization
$12.02 billion
P/E Ratio
49.03
Dividend Yield
0.82%
Price Target
€177.00

AFX stock logo

About Carl Zeiss Meditec (ETR:AFX) Stock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

AFX Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
CARL ZEISS MEDITEC AG (AFX.MU)
CARL ZEISS MEDITEC AG (AFX.DU)
Carl Zeiss Meditec AG Inhaber-A (AFX.SG)
See More Headlines
Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,531
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€177.00
High Stock Price Forecast
€215.00
Low Stock Price Forecast
€138.00
Forecasted Upside/Downside
+31.7%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$307.01 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.96 billion
Cash Flow
€0.10 per share
Book Value
€22.53 per share

Miscellaneous

Free Float
N/A
Market Cap
$12.02 billion
Optionable
Not Optionable
Beta
0.80

Key Executives

  • Mr. Justus Felix Wehmer (Age 57)
    CFO & Member of the Management Board
    Comp: $564.5k
  • Dr. Markus Weber
    Pres, CEO & Chairman of Management Board
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Mr. Martin Wiechmann
    Head of the Planetarium Bus. Unit
  • Mr. Mike Wang
    Head of Marketing - Shanghai
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.
  • Laurie Ferguson
    Head of Global Communications Ophthalmic Devices
  • Dr. Euan S. Thomson Ph.D. (Age 59)
    Pres of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Bus. Unit
  • Mr. Magnus Reibenspiess
    Head of the Microsurgery Strategic Bus. Unit - ZEISS Medical Technology













AFX Stock - Frequently Asked Questions

What is Carl Zeiss Meditec's stock price forecast for 2023?

0 brokerages have issued 12-month target prices for Carl Zeiss Meditec's stock. Their AFX share price forecasts range from €138.00 to €215.00. On average, they predict the company's share price to reach €177.00 in the next year. This suggests a possible upside of 31.7% from the stock's current price.
View analysts price targets for AFX
or view top-rated stocks among Wall Street analysts.

How have AFX shares performed in 2023?

Carl Zeiss Meditec's stock was trading at €117.90 at the start of the year. Since then, AFX shares have increased by 14.0% and is now trading at €134.35.
View the best growth stocks for 2023 here
.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec (ETR:AFX) pays an annual dividend of €1.10 per share and currently has a dividend yield of 0.80%. The dividend payout ratio is 40.15%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €134.35.

How much money does Carl Zeiss Meditec make?

Carl Zeiss Meditec (ETR:AFX) has a market capitalization of $12.02 billion and generates $1.96 billion in revenue each year. The company earns $307.01 million in net income (profit) each year or €2.74 on an earnings per share basis.

How many employees does Carl Zeiss Meditec have?

The company employs 3,531 workers across the globe.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The official website for the company is www.zeiss.com. The company can be reached via phone at +49-3641-2200.

This page (ETR:AFX) was last updated on 3/21/2023 by MarketBeat.com Staff